Surat: With the Congress raising doubts over the efficacy of COVID-19 vaccine, Union Minister Dharmendra Pradhan termed people with such mentality as 'mandh buddhi'. The Union Minister said those doubting ...
New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield, manufactured by Pune-based Serum ...
New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval ...
New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines, All India Institute Of Medical Science (AIIMS) Director Randeep Guleria ...
New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from the Drugs Controller ...
New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider SEC recommendation in granting REU approval to Bharat Biotech-developed COVAXIN. ...
New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, ...
Hyderabad: COVID-19 vaccine, Covaxin will be effective in treating the new strain that has created a panic worldwide, Bharat Biotech said on Tuesday. According to Bharat Biotech Chairman and Managing ...
New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with ...
New Delhi: The Union government dismissed media reports of Serum Institute India (SII) and Bharat Biotech’s emergency use authorisation of COVID-19 vaccine being rejected and called it “fake.” According to ...
Copyright © 2024 Frontier Media
